Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

FierceBiotechSignant Health buys Ametris to unite data streams in clinical trials

ScienceDid this scientist go too far trying to save Ecuador’s wildlife?

Endpoints NewsEncoded's gene therapy reduced seizures in Dravet syndrome

Clinical OMICsA Retina’s Biological Age Can Predict Osteoporosis Risk

Clinical OMICsWireless Stress Detector Offers Multiple Medical Uses

Endpoints NewsASGCT dispatch: In vivo CAR-T is everywhere, but still preclinical

Clinical OMICsPrior Heart Attack Linked to Faster Cognitive Decline Over Time

BioPharma DiveCreate Medicines raises $122M to bolster in vivo CAR-T therapies

FierceBiotechBioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNS

Endpoints NewsDrugmakers have to go through rigorous tests to get a lower tariff rate

BioWorldFosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

FierceBiotechBiopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?